Stone Ridge Asset Management LLC Acquires New Holdings in HCA Healthcare Inc (NYSE:HCA)

Stone Ridge Asset Management LLC acquired a new stake in HCA Healthcare Inc (NYSE:HCA) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 89,653 shares of the company’s stock, valued at approximately $12,119,000. HCA Healthcare comprises about 0.7% of Stone Ridge Asset Management LLC’s investment portfolio, making the stock its 16th biggest holding.

A number of other large investors have also recently modified their holdings of the stock. Westside Investment Management Inc. acquired a new position in HCA Healthcare during the 2nd quarter valued at about $34,000. NEXT Financial Group Inc acquired a new position in HCA Healthcare during the 2nd quarter valued at about $43,000. Rational Advisors LLC increased its stake in HCA Healthcare by 5,118.2% during the 1st quarter. Rational Advisors LLC now owns 574 shares of the company’s stock valued at $75,000 after buying an additional 563 shares during the period. Cornerstone Advisors Inc. increased its stake in HCA Healthcare by 19.6% during the 1st quarter. Cornerstone Advisors Inc. now owns 587 shares of the company’s stock valued at $77,000 after buying an additional 96 shares during the period. Finally, Alpha Windward LLC increased its stake in HCA Healthcare by 50.9% during the 2nd quarter. Alpha Windward LLC now owns 608 shares of the company’s stock valued at $89,000 after buying an additional 205 shares during the period. Hedge funds and other institutional investors own 70.32% of the company’s stock.

Shares of HCA traded down $2.46 during mid-day trading on Friday, hitting $119.78. The company’s stock had a trading volume of 1,110,797 shares, compared to its average volume of 2,017,025. The firm has a 50-day moving average price of $133.26 and a 200 day moving average price of $130.99. The stock has a market capitalization of $42.14 billion, a price-to-earnings ratio of 12.26, a PEG ratio of 1.06 and a beta of 0.85. HCA Healthcare Inc has a fifty-two week low of $110.31 and a fifty-two week high of $147.42.



HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $2.21 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.49 by ($0.28). The business had revenue of $12.60 billion during the quarter, compared to analyst estimates of $12.61 billion. HCA Healthcare had a negative return on equity of 135.90% and a net margin of 7.46%. The business’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the prior year, the firm earned $2.29 EPS. Equities research analysts forecast that HCA Healthcare Inc will post 10.36 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Tuesday, September 3rd will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.34%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s dividend payout ratio (DPR) is currently 16.38%.

HCA has been the topic of several research analyst reports. Stephens set a $150.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, August 7th. Deutsche Bank raised their target price on shares of HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Zacks Investment Research cut shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 target price on the stock. in a research note on Monday, May 27th. Mizuho set a $153.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, July 31st. Finally, Goldman Sachs Group raised shares of HCA Healthcare from a “neutral” rating to a “buy” rating and raised their target price for the company from $147.00 to $160.00 in a research note on Wednesday, July 10th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and seventeen have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $153.35.

In other news, SVP Robert A. Waterman sold 33,786 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $134.98, for a total value of $4,560,434.28. Following the transaction, the senior vice president now directly owns 279,551 shares of the company’s stock, valued at $37,733,793.98. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Patricia F. Elcan bought 250 shares of the company’s stock in a transaction dated Tuesday, August 6th. The stock was purchased at an average cost of $124.10 per share, for a total transaction of $31,025.00. The disclosure for this purchase can be found here. Company insiders own 2.70% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: What is required to own or exchange cryptocurrency?

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.